Ultragenyx Pharmaceutical careers

BioMarin, Shire, Genzyme, Hyperion, Synageva, Swedish Orphan-Biovitrum, SOBI, Sarepta, Prosensa, PTC Therapeutics and Ultragenyx, biotech, biotechnology, pharmaceutical, biologic, small molecule, drugs, rare disease, orphan product, ultra rare disease, enzyme, enzyme replacement therapy, triheptanoin, krn23, rhGUS, sialic acid, SA-ER, XLH, x-linked hypophosphatemia, MPS VII, MPS 7, mucopolysaccharidosis, sly disease, sly syndrome, FAOD, Glut1 Deficiency Syndrome, HIBM, hereditary inclusion body myopathy, GNE myopathy, C7, rickets, renal phosphate, DMRV, Nonaka disease, De Vivo disease, LCHAD, CPT2, VLCAD, TFP, CACT, CTD, MCAD, clinical trials, drug development, Emil Kakkis, metabolic, inborn errors of metabolism, muscle wasting, myopathy, myositis, distal myopathy with rimmed vacuoles, anti-FGF23, monoclonal antibody, UX001, UX003, UX007, UK007G, UX023, bone deformity, osteomalacia, microfractures, fatty acid oxidation disorders, galactosialidosis, epilepsy, absence seizures, substrate replacement, vitamin D-resistant rickets, lysosomal storage disease